Sale!

RAB7A Gene CMT2B Genetic Test

4,400 د.إ

-21%

The RAB7A Gene CMT2B Genetic Test is a specialized diagnostic tool designed to identify mutations in the RAB7A gene, which are associated with Charcot-Marie-Tooth disease type 2B (CMT2B). CMT2B is a rare form of Charcot-Marie-Tooth disease, a group of disorders that affect the peripheral nerves, leading to muscle weakness and sensory problems, primarily in the feet and legs, sometimes affecting the hands and arms in the advanced stages of the disease.

This test is crucial for patients exhibiting symptoms of CMT2B or those with a family history of the condition, as it provides definitive genetic evidence of the RAB7A mutation. Early and accurate diagnosis through the RAB7A Gene CMT2B Genetic Test can significantly impact the management and treatment options for affected individuals, allowing for personalized care plans that can improve quality of life.

The test is available at DNA Labs UAE, a leading facility in genetic testing and diagnostics, ensuring high standards of accuracy and reliability. The cost of the test is set at 4400 AED, reflecting the specialized nature of the analysis and the sophisticated technology used to identify the genetic mutation. By opting for this test at DNA Labs UAE, patients and their families can expect comprehensive support, from the initial consultation through to the interpretation of results and guidance on subsequent steps.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

RAB7A Gene CMT2B Genetic Test

At DNA Labs UAE, we offer the RAB7A Gene CMT2B Genetic Test for individuals who may be affected by Charcot-Marie-Tooth disease type 2B (CMT2B). This progressive neurological disorder affects the peripheral nerves and is characterized by muscle weakness and wasting, sensory loss, and foot deformities.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the RAB7A Gene CMT2B NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with RAB7A Gene CMT2B. This information helps in the accurate analysis and interpretation of the test results.

Test Details

The RAB7A gene is associated with Charcot-Marie-Tooth disease type 2B (CMT2B). NGS (next-generation sequencing) genetic testing is used to analyze the RAB7A gene and identify any mutations or variations that may be associated with CMT2B. Compared to traditional Sanger sequencing, NGS testing provides a more comprehensive analysis of the gene, allowing for a more accurate diagnosis.

NGS testing involves sequencing the entire RAB7A gene or specific regions of interest, such as exons or introns. The results of this test can help healthcare providers determine the best course of treatment and management for individuals with CMT2B.

Test Name RAB7A Gene CMT2B Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for RAB7A Gene CMT2B NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with RAB7A Gene CMT2B
Test Details

The RAB7A gene is associated with Charcot-Marie-Tooth disease type 2B (CMT2B), a progressive neurological disorder that affects the peripheral nerves. CMT2B is characterized by muscle weakness and wasting, sensory loss, and foot deformities.

NGS (next-generation sequencing) genetic testing can be used to analyze the RAB7A gene and identify any mutations or variations that may be associated with CMT2B. This type of testing can provide a more comprehensive analysis of the gene compared to traditional Sanger sequencing, allowing for a more accurate diagnosis.

NGS testing typically involves sequencing the entire RAB7A gene or specific regions of interest, such as exons or introns. The results can help healthcare providers determine the best course of treatment and management for individuals with CMT2B.